TOBACCO-FREE KIDS ACTION FUND
Lobbying for TOBACCO-FREE KIDS ACTION FUND · 501(c)(4) organization
Lobbying Report: January 1st - March 31st, 2026 (Action Fund) Federal (under tobacco issue code) Legislation: H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA enforcement against unauthorized tobacco products FDA review of flavored e-cigarettes FDA oversight of nicotine pouches Tobacco Harm Reduction Caucus Agencies Visited: Food and Drug Administration US House of Representatives US Senate
GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 26 Appropriations bills Modernizing Opioid Treatment Access Act PEER Support Act H.R. 5420 - Workplace Overdose Reversal Kits to Save Lives Act S.3522 - No Red Tape For Addiction Treatment Act S. 1165/H. R. 2586, Reentry Act S. 1720/H.R. 1510, Due Process Continuity of Care Act S. 2697, Due Process Continuity of Care Act SUPPORT for Patients and Communities Reauthorization Act Issues: Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate